The World Health Organization said on Tuesday there was a serious risk that the chikungunya virus would cause a major epidemic worldwide and called for urgent action to prevent that scenario.
The U.S. Food and Drug Administration (FDA) has approved a new prefilled syringe formulation of Shingrix (shingles vaccine, recombinant, adjuvanted) for the prevention of shingles (herpes zoster).
In 2024, 89% of infants worldwide – about 115 million – will have received at least one dose of a vaccine containing diphtheria, tetanus and pertussis (DTP), and 85% – about 109 million – will have completed the full three-dose course.
